iShares Genomics Immunology and Healthcare ETF
IDNA
89 hedge funds and large institutions have $104M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 13 reducing their positions, and 6 closing their positions.
162% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 13
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
6% more funds holding
Funds holding: 84 → 89 (+5)
6% more capital invested
Capital invested by funds: $98.7M → $104M (+$5.44M)
0.27% more ownership
Funds ownership: 27.44% → 27.7% (+0.27%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$9.95M |
| 2 |
PWP
Principle Wealth Partners
Madison,
Connecticut
|
+$2.79M |
| 3 |
Morgan Stanley
New York
|
+$2.28M |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$733K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$560K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCS
Retirement Capital Strategies
San Jose,
California
|
-$4.54M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.59M |
| 3 |
Jane Street
New York
|
-$843K |
| 4 |
LPL Financial
San Diego,
California
|
-$562K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$353K |
IDNA Hedge Fund Activity: Q3 2021 in Review
89 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2021, worth a combined $104M — up 5.5% from $98.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IDNA positions and 6 closed out — a net gain of 6 holders — while 34 added to existing stakes and 13 trimmed.
The largest buyer was Bank of America, adding an estimated $9.95M. The largest seller was Retirement Capital Strategies, cutting an estimated $4.54M.
- 89 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2021, up from 84 in Q2 2021.
- Funds reported $104M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2021, up 5.5% quarter-over-quarter.
- 12 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2021 and 6 closed out, a net change of +6 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2021 was Bank of America, an estimated $9.95M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2021 was Retirement Capital Strategies, an estimated $4.54M sold.
Based on aggregated 13F filings for Q3 2021.